论文部分内容阅读
目的探讨痰热清注射液治疗小儿支气管肺炎的临床疗效。方法将78例支气管炎肺炎患儿随机分为观察组和对照组,各39例,对照组仅予常规治疗,观察组在常规治疗的基础上加用痰热清注射液,疗程7天。观察两组患儿临床症状和体征恢复情况。结果观察组临床症状和体征消失时间短于对照组,差异有统计学意义(P<0.05);观察组总有效率为97.43%,对照组总有效率为84.62%,两组比较差异有统计学意义(P<0.05);观察组无明显不良反应发生。结论痰热清注射液治疗小儿支气管肺炎疗效显著,用药安全,值得临床推广。
Objective To investigate the clinical efficacy of Tanreqing injection in the treatment of bronchial pneumonia in children. Methods 78 cases of children with bronchitis pneumonia were randomly divided into observation group and control group, 39 cases in each group. The control group was treated only routinely. The observation group was given Tanreqing injection on the basis of routine treatment for 7 days. The clinical symptoms and signs recovered in both groups were observed. Results The disappearance time of clinical symptoms and signs in the observation group was shorter than that in the control group (P <0.05). The total effective rate in the observation group was 97.43% and that in the control group was 84.62%. The difference between the two groups was statistically significant Significance (P <0.05); observation group no obvious adverse reactions. Conclusion Tanreqing injection for the treatment of children with bronchial pneumonia significant effect, drug safety, it is worth clinical promotion.